Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use

Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1). Also disclosed are pharmaceutical compositions conta...

Full description

Saved in:
Bibliographic Details
Main Authors PERRYMAN, Alexander, LIU, Bingcan, VALLÉE, Frédéric, TRUCHON, Jean-François, SZYCHOWSKI, Janek, DIETRICH, Evelyne, BEAULIEU, Patrick, PAPP, Robert
Format Patent
LanguageEnglish
Published 17.11.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1). Also disclosed are pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and methods of their preparation and use.
Bibliography:Application Number: AU20210250744